Viva Biotech Holdings (VB0) — Cash Flow Reinvestment Rate
Viva Biotech Holdings (VB0) has a Cash Flow Reinvestment Rate of 0.37x as of June 2023, reinvesting €57.96 Million (capex €50.80 Million plus investments €7.15 Million) from operating cash flow of €158.72 Million. Check VB0 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Viva Biotech Holdings Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Viva Biotech Holdings across 9 annual periods. Explore VB0 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Viva Biotech Holdings (2016–2024)
Year-by-year capital reinvestment analysis for Viva Biotech Holdings. For live market cap and broader valuation context, see how much is Viva Biotech Holdings worth.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.91x | €340.66 Million | €373.99 Million | €191.67 Million | ▲ +45.0% |
| 2023 | 0.63x | €240.78 Million | €383.40 Million | €187.84 Million | ▼ -18.5% |
| 2022 | 0.77x | €297.35 Million | €386.05 Million | €249.33 Million | ▼ -91.7% |
| 2021 | 9.31x | €724.23 Million | €77.83 Million | €565.18 Million | ▼ -44.0% |
| 2020 | 16.61x | €717.04 Million | €43.18 Million | €592.62 Million | ▲ +219.8% |
| 2019 | 5.19x | €238.95 Million | €46.01 Million | €56.19 Million | ▼ -14.4% |
| 2018 | 6.07x | €73.46 Million | €12.11 Million | €46.90 Million | ▲ +484.9% |
| 2017 | 1.04x | €28.92 Million | €27.89 Million | €18.92 Million | ▼ -18.7% |
| 2016 | 1.28x | €26.93 Million | €21.12 Million | €7.34 Million | — |